Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Deficit

v3.20.4
Consolidated Statements of Stockholders' Deficit - USD ($)
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Other Comprehensive Income [Member]
Other Comprehensive Income [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Beginning balance at Nov. 30, 2018 $ (8,908,298)   $ 135,964 $ 35,515,382 $ (19,571,113) $ 340,984   $ (25,329,515)  
Beginning balance (Accounting Standards Update 2016-01 [Member]) at Nov. 30, 2018             $ (340,984)   $ 340,984
Beginning balance (ASC 606 [Member]) at Nov. 30, 2018   $ 253,447             $ 253,447
Beginning balance, shares at Nov. 30, 2018     13,596,409            
Common stock issued 5,700   $ 25 5,675          
Common stock issued, shares     2,500            
Compensatory element of stock options 397,770     397,770          
Treasury Stock (992,244)       (992,244)        
Net income 2,290,774             2,290,774  
Ending balance at Nov. 30, 2019 (6,952,851)   $ 135,989 35,918,827 (20,563,357)     (22,444,310)  
Ending balance, shares at Nov. 30, 2019     13,598,909            
Common stock issued 41,000   $ 347 40,653          
Common stock issued, shares     34,729            
Compensatory element of stock options 622,120     622,120          
Net income 3,624,596             3,624,596  
Ending balance at Nov. 30, 2020 $ (2,665,135)   $ 136,336 $ 36,581,600 $ (20,563,357)     $ (18,819,714)  
Ending balance, shares at Nov. 30, 2020     13,633,638